A fascinating glimpse inside the life-and-death business of
biotechnology.
"A tour-de-force for anyone who is interested in the biotech
industry. I applaud the enormous achievement of Cynthia
Robbins-Roth." -Frederick Frank, Senior Managing Director &
Vice Chair, Lehman Brothers
"From Alchemy to IPO tells the dramatic story of this
revolutionary industry as only an insider can." -George Rathmann,
President and CEO, ICOS Corporation, Chairman Emeritus, Amgen
Written by a well-known industry insider, From Alchemy to IPO
addresses the coming-of-age of biotech products and companies and
traces the history of biotechnology from its early inception in the
seventies to today's heyday of new solutions and breakthrough
treatments. It describes the amazing entrepreneurial trail of
product development, novel business models, and critical trials
that eventually pave the way to market. This is the first book to
accurately record the inner workings of an
industry-biotechnology-that's on the verge of living up to its
monumental promise to change the world as we know it.